Metraipolis › archive › dc_85ed8e0879bb

CAP-LAMP2b-Modified Stem Cells' Extracellular Vesicles Hybrid with CRISPR-Cas9 Targeting ADAMTS4 to Reverse IL-1β-Induced Aggrecan Loss in Chondrocytes — Europe PMC PMID:41097079

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41097079
DOI
10.3390/ijms26199812
License (as archived)
solo-consultazione
Archived
2026-11-09T10:40:05.663Z
SHA-256 of the archived text
3bf7de6f0270029ab5bdad0cf56577bdfa52f19fff5bd5e3d898e77ec58f4cbb
Stable URL of this page
https://metraipolis.com/documento/dc_85ed8e0879bb

How to cite

CAP-LAMP2b-Modified Stem Cells' Extracellular Vesicles Hybrid with CRISPR-Cas9 Targeting ADAMTS4 to Reverse IL-1β-Induced Aggrecan Loss in Chondrocytes — Europe PMC PMID:41097079 — Europe PMC (en), https://europepmc.org/article/MED/41097079 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_85ed8e0879bb (Metraipolis archive dc_85ed8e0879bb, sha256 3bf7de6f0270029ab5bdad0cf56577bdfa52f19fff5bd5e3d898e77ec58f4cbb)
BibTeX
@misc{dc85ed8e0879bb,
  title = {CAP-LAMP2b-Modified Stem Cells' Extracellular Vesicles Hybrid with CRISPR-Cas9 Targeting ADAMTS4 to Reverse IL-1β-Induced Aggrecan Loss in Chondrocytes — Europe PMC PMID:41097079},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41097079},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_85ed8e0879bb; sha256 3bf7de6f0270029ab5bdad0cf56577bdfa52f19fff5bd5e3d898e77ec58f4cbb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41097079. Agents can read the archived copy with the MCP tool read_document.